Rage Biotech

Recent Finacing

Series A

Recent Raise

$19M

RAGE Biotech is an Australian Monash University spin-off developing next-generation RNA-based therapeutics that modulate the RAGE inflammatory pathway to treat chronic inflammatory diseases.

Victoria, Australia

1-10

Private

ragebiotech.com